Vaccine doses for people with the risk conditions in this list are funded under the NIP unless otherwise noted.


Immunocompromising conditions including: 

  • HIV infection
  • malignancy
  • chronic steroid use
  • solid organ transplant
  • haematopoietic stem cell transplant

Functional or anatomical asplenia, including:

  • sickle cell disease or other haemoglobinopathies
  • congenital or acquired asplenia (for example, splenectomy) or hyposplenia

Cardiac disease, including:

  • cyanotic congenital heart disease
  • congestive heart failure
  • coronary artery

Chronic respiratory conditions, including:

  • suppurative lung disease
  • bronchiectasis 
  • cystic fibrosis
  • chronic obstructive pulmonary disease
  • chronic emphysema
  • Severe asthma (requiring frequent medical consultations or the use of multiple medicines)

Chronic neurological conditions, including:

  • hereditary and degenerative CNS diseases
  • seizure disorders
  • spinal cord injuries
  • neuromuscular disorders

Chronic metabolic disorders, including:

  • Type 1 or 2 diabetes
  • amino acid disorders
  • carbohydrate disorders
  • cholesterol biosynthesis disorders
  • fatty acid oxidation defects, lactic acidosis
  • mitochondrial disorders
  • organic acid disorders
  • urea cycle disorders
  • vitamin/cofactor disorders
  • porphyrias
Chronic renal failure
Long-term aspirin therapy in children aged 6 months to 10 years
Chronic liver diseasea
Down syndromea
Obesity (body mass index ≥30 kg per m2) a
Children born less than 37 weeks gestationa
Harmful use of alcohola

a: Not funded under the NIP

Last updated: 
13 April 2021
Last reviewed: 
13 April 2021